Completed NCT01238575
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Los Angeles Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance. From 5 Years to 14 Years
Countries United States
Sponsor Yale University
Condition ADHD Completed NCT02655276
This summary needs review. Please check the official study record and contact the research team for details.
In Freiburg im Breisgau Why is this study shown? This study is directly about ADHD.
ADHD Other From 6 Years to 14 Years
Countries Germany
Sponsor Eberhard Schulz
Condition ADHD Completed NCT03495375
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Frankfurt Why is this study shown? This study is directly about ADHD.
ADHD Other From 18 Years to 65 Years
Countries Germany, Hungary, Spain
Sponsor Hospital Vall d'Hebron
Condition ADHD Completed NCT00364702
This summary needs review. Please check the official study record and contact the research team for details.
In Jerusalem Why is this study shown? This study is directly about ADHD.
ADHD Drug From 10 Years to 20 Years
Countries Israel
Sponsor Shaare Zedek Medical Center
Condition ADHD Recruitment unclear EUCTR 2013-003731-29
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Norway Why is this study shown? This study is directly about ADHD.
ADHD Drug
Countries Norway
Sponsor SSE, Nevroklinikken, Oslo Universitetssykehus
Condition ADHD Completed NCT01931644
This summary needs review. Please check the official study record and contact the research team for details.
In Los Angeles Why is this study shown? This study is directly about ADHD.
ADHD, Bipolarity, ... Observational i A study where researchers collect information without assigning a treatment. From 18 Years to 100 Years
Countries United States
Sponsor Sanguine Biosciences
Condition ADHD, Bipolarity, ... Withdrawn NCT05273918
This study was withdrawn in France. It focuses on ADHD.
Multiple locations, including Bordeaux Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 7 Years to 13 Years
Countries France
Sponsor Centre Hospitalier Universitaire de la Réunion
Condition ADHD Completed NCT00919906
This summary needs review. Please check the official study record and contact the research team for details.
In Eugene Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 5 Years to 19 Years
Countries United States
Sponsor Obslap Research LLC
Condition ADHD Completed NCT06691646
This summary needs review. Please check the official study record and contact the research team for details.
In Nottingham Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 18 Years to 30 Years
Countries United Kingdom
Sponsor University of Nottingham
Condition ADHD Terminated NCT01000064
This summary needs review. Please check the official study record and contact the research team for details.
In Nashville Why is this study shown? This study is directly about ADHD.
ADHD Drug From 16 Years to 45 Years
Countries United States
Sponsor Vanderbilt University
Condition ADHD Completed NCT02712996
This summary needs review. Please check the official study record and contact the research team for details.
In Nashville Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 16 Years
Countries United States
Sponsor Vanderbilt University
Condition ADHD Terminated EUCTR 2018-001166-42
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Italy Why is this study shown? This study is directly about ADHD.
ADHD Drug
Countries Italy, Spain
Sponsor Aziende Chimiche Riunite Angelini Francesco ACRAF S.p.A (Angelini S.p.A.)
Condition ADHD